Skip to Main Content

Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial (CHASM CS- RCT)

Conditions

Diseases of the Cardiovascular System

Phase III

What is the purpose of this trial?

The purpose of this study is to compare the effects of low dose prednisone combined with methotrexate to see if it will be as effective, and better tolerated than the standard dose of prednisone alone in the treatment of cardiac sarcoidosis.

  • Trial with
    Ottawa Hospital Research Institute
  • Start Date
    12/15/2020
  • End Date
    12/30/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000027643